MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1

被引:16
作者
Lin, Tao [1 ]
Ma, Quanping [2 ]
Zhang, Yuefeng [3 ]
Zhang, Hongfei [4 ]
Yan, Jiapeng [4 ]
Gao, Changhong [1 ]
机构
[1] Shandong Univ, Jinan Cent Hosp, Dept Orthoped, 105 Jiefang Rd, Jinan 250000, Shandong, Peoples R China
[2] Jinan Fourth Peoples Hosp, Clin Lab, Jinan 250000, Shandong, Peoples R China
[3] Shandong Yellow River Hosp, Major Surg, Jinan 250000, Shandong, Peoples R China
[4] Weifang Med Univ, Affiliated Hosp, Dept Orthoped, Weifang 261031, Shandong, Peoples R China
关键词
microRNA-27a; osteosarcoma; cyclin G1; migration; invasion; GASTRIC-CANCER; CYCLIN G1; CELLS; PROLIFERATION; PATHOGENESIS; SIGNATURES; INVASION; PROTEIN; MIR-27A; GROWTH;
D O I
10.3892/ol.2017.7389
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteosarcoma is the most common type of malignant tumor arising from bone in children and adolescents. Accumulating evidences have shown the aberrant expression of numerous miRNAs is associated with the development and metastasis of osteosarcoma. The present study was conducted to investigate miR-27a expression in osteosarcoma tissues and cells. In the present study, quantitative RT-qPCR was used to measure the expression levels of miRNA and mRNA in osteosarcoma tissues and cells. Transwell assays were used to detect the effects of miR-27a on the invasive and migratory potential of cells. Luciferase reporter and western blot analysis were conducted to confirm cyclin G1 (CCNG1) as the target gene of miR-27a. The results showed that miR-27a was significantly upregulated in human osteosarcoma tissues and cell lines. The western blot analysis revealed that the overexpression of miR-27a suppressed CCNG1 protein expression. Luciferase reporter assays confirmed that CCNG1 is a direct target of miR-27a in osteosarcoma cells. The results suggest that mi R-27a downregulates CCNG1 expression in osteosarcoma and acts as an oncogene directly targeting CCNG1. Thus, the miR-27a/CCNGI axis is a potential therapeutic target for human osteosarcoma.
引用
收藏
页码:1067 / 1071
页数:5
相关论文
共 32 条
  • [1] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [2] Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248
  • [3] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [4] Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice
    Chen, DS
    Zhu, NL
    Hung, G
    Skotzko, MJ
    Hinton, DR
    Tolo, V
    Hall, FL
    Anderson, WF
    Gordon, EM
    [J]. HUMAN GENE THERAPY, 1997, 8 (14) : 1667 - 1674
  • [5] Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance
    Danza, Katia
    Silvestris, Nicola
    Simone, Giovanni
    Signorile, Michele
    Saragoni, Luca
    Brunetti, Oronzo
    Monti, Manlio
    Mazzotta, Annalisa
    De Summa, Simona
    Mangia, Anita
    Tommasi, Stefania
    [J]. CANCER BIOLOGY & THERAPY, 2016, 17 (04) : 400 - 406
  • [6] The Sequence Structures of Human MicroRNA Molecules and Their Implications
    Fang, Zhide
    Du, Ruofei
    Edwards, Andrea
    Flemington, Erik K.
    Zhang, Kun
    [J]. PLOS ONE, 2013, 8 (01):
  • [7] Ferrari S, 2002, J CLIN ONCOL, V20, P2910, DOI 10.1200/JCO.2002.20.12.2910
  • [8] MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
    Fornari, Francesca
    Gramantieri, Laura
    Giovannini, Catia
    Veronese, Angelo
    Ferracin, Manuela
    Sabbioni, Silvia
    Calin, George Adrian
    Grazi, Gian Luca
    Croce, Carlo Maria
    Tavolari, Simona
    Chieco, Pasquale
    Negrini, Massimo
    Bolondi, Luigi
    [J]. CANCER RESEARCH, 2009, 69 (14) : 5761 - 5767
  • [9] Effect of miR27a on Proliferation and Invasion in Colonic Cancer Cells
    Gao, Yang
    Li, Bao-Dong
    Liu, Yong-Gang
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (08) : 4675 - 4678
  • [10] Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705